These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 26998714)
1. Effect of the Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) on Corneal Endothelial Wound Healing. Okumura N; Okazaki Y; Inoue R; Kakutani K; Nakano S; Kinoshita S; Koizumi N Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):1284-92. PubMed ID: 26998714 [TBL] [Abstract][Full Text] [Related]
2. Effect of the Rho Kinase Inhibitor Y-27632 on Corneal Endothelial Wound Healing. Okumura N; Inoue R; Okazaki Y; Nakano S; Nakagawa H; Kinoshita S; Koizumi N Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):6067-74. PubMed ID: 26393474 [TBL] [Abstract][Full Text] [Related]
3. Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Transiently Alters the Morphology of Corneal Endothelial Cells. Okumura N; Okazaki Y; Inoue R; Nakano S; Fullwood NJ; Kinoshita S; Koizumi N Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7560-7. PubMed ID: 26618648 [TBL] [Abstract][Full Text] [Related]
4. The ROCK inhibitor eye drop accelerates corneal endothelium wound healing. Okumura N; Koizumi N; Kay EP; Ueno M; Sakamoto Y; Nakamura S; Hamuro J; Kinoshita S Invest Ophthalmol Vis Sci; 2013 Apr; 54(4):2493-502. PubMed ID: 23462749 [TBL] [Abstract][Full Text] [Related]
5. Morphological Changes of Human Corneal Endothelial Cells after Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Administration: A Prospective Open-Label Clinical Study. Nakagawa H; Koizumi N; Okumura N; Suganami H; Kinoshita S PLoS One; 2015; 10(9):e0136802. PubMed ID: 26367375 [TBL] [Abstract][Full Text] [Related]
6. Effects of ripasudil hydrochloride hydrate (K-115), a Rho-kinase inhibitor, on ocular blood flow and ciliary artery smooth muscle contraction in rabbits. Ohta Y; Takaseki S; Yoshitomi T Jpn J Ophthalmol; 2017 Sep; 61(5):423-432. PubMed ID: 28653193 [TBL] [Abstract][Full Text] [Related]
7. Involvement of cyclin D and p27 in cell proliferation mediated by ROCK inhibitors Y-27632 and Y-39983 during corneal endothelium wound healing. Okumura N; Nakano S; Kay EP; Numata R; Ota A; Sowa Y; Sakai T; Ueno M; Kinoshita S; Koizumi N Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):318-29. PubMed ID: 24106120 [TBL] [Abstract][Full Text] [Related]
8. Vascular Normalization by ROCK Inhibitor: Therapeutic Potential of Ripasudil (K-115) Eye Drop in Retinal Angiogenesis and Hypoxia. Yamaguchi M; Nakao S; Arita R; Kaizu Y; Arima M; Zhou Y; Kita T; Yoshida S; Kimura K; Isobe T; Kaneko Y; Sonoda KH; Ishibashi T Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2264-76. PubMed ID: 27124322 [TBL] [Abstract][Full Text] [Related]
9. Y-27632 Promotes the Repair Effect of Umbilical Cord Blood-Derived Endothelial Progenitor Cells on Corneal Endothelial Wound Healing. Zhang W; Shao C; Yu F; Chen J; Fu Y; Fan X Cornea; 2021 Feb; 40(2):203-214. PubMed ID: 33086282 [TBL] [Abstract][Full Text] [Related]
10. Potential Functional Restoration of Corneal Endothelial Cells in Fuchs Endothelial Corneal Dystrophy by ROCK Inhibitor (Ripasudil). Schlötzer-Schrehardt U; Zenkel M; Strunz M; Gießl A; Schondorf H; da Silva H; Schmidt GA; Greiner MA; Okumura N; Koizumi N; Kinoshita S; Tourtas T; Kruse FE Am J Ophthalmol; 2021 Apr; 224():185-199. PubMed ID: 33316261 [TBL] [Abstract][Full Text] [Related]
11. Topical Rho-Associated Kinase Inhibitor, Y27632, Accelerates Corneal Endothelial Regeneration in a Canine Cryoinjury Model. Miyagi H; Kim S; Li J; Murphy CJ; Thomasy SM Cornea; 2019 Mar; 38(3):352-359. PubMed ID: 30516555 [TBL] [Abstract][Full Text] [Related]
12. The ROCK Inhibitor Ripasudil Shows an Endothelial Protective Effect in Patients With Low Corneal Endothelial Cell Density After Cataract Surgery. Fujimoto H; Setoguchi Y; Kiryu J Transl Vis Sci Technol; 2021 Apr; 10(4):18. PubMed ID: 34003995 [TBL] [Abstract][Full Text] [Related]
14. Enhanced Migration of Fuchs Corneal Endothelial Cells by Rho Kinase Inhibition: A Novel Ex Vivo Descemet's Stripping Only Model. Parekh M; Miall A; Chou A; Buhl L; Deshpande N; Price MO; Price FW; Jurkunas UV Cells; 2024 Jul; 13(14):. PubMed ID: 39056800 [TBL] [Abstract][Full Text] [Related]
15. Increase in the OCT angiographic peripapillary vessel density by ROCK inhibitor ripasudil instillation: a comparison with brimonidine. Chihara E; Dimitrova G; Chihara T Graefes Arch Clin Exp Ophthalmol; 2018 Jul; 256(7):1257-1264. PubMed ID: 29520478 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma. Kusuhara S; Katsuyama A; Matsumiya W; Nakamura M Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):809-814. PubMed ID: 29468405 [TBL] [Abstract][Full Text] [Related]
17. Nicotinamide inhibits corneal endothelial mesenchymal transition and accelerates wound healing. Li Z; Duan H; Li W; Jia Y; Zhang S; Zhao C; Zhou Q; Shi W Exp Eye Res; 2019 Jul; 184():227-233. PubMed ID: 31028751 [TBL] [Abstract][Full Text] [Related]
18. Use of Topical Rho Kinase Inhibitors in the Treatment of Fuchs Dystrophy After Descemet Stripping Only. Macsai MS; Shiloach M Cornea; 2019 May; 38(5):529-534. PubMed ID: 30720541 [TBL] [Abstract][Full Text] [Related]
19. The new therapeutic concept of using a rho kinase inhibitor for the treatment of corneal endothelial dysfunction. Okumura N; Koizumi N; Ueno M; Sakamoto Y; Takahashi H; Hamuro J; Kinoshita S Cornea; 2011 Oct; 30 Suppl 1():S54-9. PubMed ID: 21912232 [TBL] [Abstract][Full Text] [Related]
20. Changes in corneal endothelial cell shape after treatment with one drop of ROCK inhibitor. Matsumura R; Inoue K; Shiokawa M; Ono M; Tanihara H; Ishida K; Tomita G Int Ophthalmol; 2020 Feb; 40(2):411-417. PubMed ID: 31664638 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]